Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Immunogenicity and Safety of Inactivated Hepatitis A Vaccine in HIV-infected People
NCT06576024Phase 4Completed
- Sponsor
- Liuzhou People's Hospital
- Start
- Dec 2023
- Primary completion
- Apr 2025
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 1
01
Overview
A Phase 4 trial of hepatitis A vaccine inactivated in hepatitis A (HAV), sponsored by Liuzhou People's Hospital. Started Dec 2023; status: completed.
02
Drugs
hepatitis A vaccine inactivated
03
Conditions
hepatitis A (HAV)
Beyond the preview
Go deeper on NCT06576024.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06576024.